Attention-deficit hyperactivity disorder and intellectual disability: A study of association with brain-derived neurotrophic factor gene polymorphisms

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 873-880

  Aureli, A ^a   Del Beato, T ^a   Sebastiani, P ^a   Marimpietri, A ^b   Melillo, C V ^b   Sechi, E ^b   Di Loreto, Silvia ^a  

^a Institute for Organ Transplantation and Immunocytology (ITOI) CNR   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

ADHD; BDNF; Intellectual disability; Polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78149243843     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300323     Document Type: Article

References (30)

1. Bernd P. The role of neurotrophins during early development. Gene Expr 2008; 14:241-50.
2. Cargill M, Altshuler D, Ireland J, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics 1999; 22:231-8.
3. Kunugi H, Ueki A, Otsuka M, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associatedwith late-onset Alzheimer's disease. Mol Psychiatry 2001; 6:83-86.
4. Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24:4401-11.
5. Aureli A, Sebastiani P, Del Beato T, et al. Investigation on the possible relationship existing between the HLA-DR gene and attention deficit hyperactivity disorder and/or mental retardation. Int J Immunopathol Pharmacol 2008; 21:985-91.
6. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001; 411:86-9
7. Blochl A, Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J Biol Chem 1996; 271:21100-7.
8. Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 2003; 119:767-75.
9. Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J. Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther 2008; 14:153-64.
10. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19:1290-300.
11. Rios M, Fan G, Fekete C, et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001; 15:1748-57.
12. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:1239-47.
13. McCormick LH. Depression in mothers of children with attention-deficit hyperactivity disorder. Fam Med 1995; 27:176-9.
14. Tsai SJ. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med Hypotheses 2007; 68:896-9
15. Conover JC, Erickson JT, Katz DM, et al. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 1995; 375:235-8.
16. Filipek PA., Semrud-Clikeman M, Steingard RJ, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48:589-601.
17. Cellerino A, Carroll P, Thoenen H, Barde YA. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci 1997; 9:397-408.
18. Overmeyer S, Bullmore E T, Suckling J, et al. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med 2001; 31:1425-35.
19. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22:123-31.
20. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001; 2:24-32.
21. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112:257-69.
22. Lippmann M, Bress A, Nemeroff CB, et al. Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci 2007; 25:3091-8.
23. Yu H, Zhang Z, Shi Y, et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 2008; 69:1104-11.
24. Lanktree M, Muglia P, Squassina A, et al. A potential role for brain-derived neurotrophic factor (BDNF) in adult ADHD. Am J Med Gent 2004; 130B:96-7.
25. Kent L, Green E, Hawi Z, et al. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry 2005; 10:939-43.
26. Schimmelmann BG, Friedel S, Dempfle A, et al. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J Neural Transm 2007; 114:523-6.
27. Xu X, Mill J, Zhou K, et al. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:83-6.
28. Gadow KD, Roohi J, Devincent CJ, et al. Association of COMT (Val158Met) and BDNF (Val66Met) Gene Polymorphisms with Anxiety, ADHD and tics in children with autism spectrum disorder. J Autism Dev Disord 2009; 39:1542-51.
29. Sánchez-Mora C, Ribasés M, Ramos-Quiroga JA, et al. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:512-23.
30. Hariri AR, Goldberg TE, Mattay VS, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23:6690-4.